In one paragraphArticle in American journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Eri EguchiDivision of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0002-1598-1847 Anna PrizmentDepartment of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0001-5924-6871 Shuo WangDepartment of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, MN, United States.
Sanaz SedaghatDivision of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States.
Mako NagayoshiDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Susan A Everson-RoseDepartment of Medicine, University of Minnesota Medical School, Minneapolis, MN, United States.ORCID 0000-0002-9839-2537 Kevin J SullivanDepartment of Medicine, The MIND Center, University of Mississippi Medical Center, Jackson, MS, United States.ORCID 0000-0001-9147-0988 Ganga BeyDepartment of Epidemiology, Gilling School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.ORCID 0000-0002-9659-7096 Anna Kucharska-NewtonDepartment of Epidemiology, Gilling School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.ORCID 0000-0001-9864-467X Weihua GuanDivision of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, United States.
Pamela L LutseyDivision of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0002-1572-1340 Funding
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UM1TR004405 · NCATS · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar, Damien A Fair · 2023 to 2026
$30.8MTHE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00003 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA · 2022 to 2025
$5.1MProfiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular DiseaseR01HL134320 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI BALLANTYNE, CHRISTIE MITCHELL, SELVIN, ELIZABETH · 2016 to 2019
$3.1MProteomic aging in adults before and after cancer diagnosisR01CA267977 · NCI · UNIVERSITY OF MINNESOTA · PI PRIZMENT, ANNA · 2022 to 2024
$1.0MMentoring and Research in Patient-Oriented Cardiovascular PharmacoepidemiologyK24HL159246 · NHLBI · UNIVERSITY OF MINNESOTA · PI PAMELA L. Lutsey · 2021 to 2026
$644kProteomic aging clock and brain structure, cognitive decline and the risk of Alzheimers Disease and related dementiasR21AG079242 · NIA · UNIVERSITY OF MINNESOTA · PI PRIZMENT, ANNA, SEDAGHAT, SANAZ · 2022 to 2022
$400kNational Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services 75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, and 75N92022D00005National Institutes of Health's National Center for Advancing Translational Sciences 1UM1TR004405NCATS NIH HHS UM1 TR004405NCI NIH HHS R01 CA267977NHLBI NIH HHS 75N92022D00003NHLBI NIH HHS K24 HL159246NHLBI NIH HHS R01 HL134320NIA NIH HHS R21 AG079242
6 · The paper itselfAbstract
We examined the associations of social network size and social support with biological age acceleration using a protein-based aging clock. A total of 11 719 participants (mean age, 57.1 ± 5.7 years; 55.6% female) of the Atherosclerosis Risk in Communities (ARIC) study Visit 2 (1990-1992) were included. Biological age was calculated using a proteomic aging clock (PAC), and age acceleration was defined as the residuals after regressing the PAC on chronological age. The associations of self-reported social network size and level of support with standardized mean age acceleration were examined using multivariable linear regression. Size of social networks and level of support were inversely associated with age acceleration. The age accelerations of small, medium, and large social networks were 0.24, 0.08, and -0.05 (P for trend = 0.003), while for low, moderate, and high levels of support the age accelerations were 0.33, 0.19, and -0.06 (P for trend < 0.0001), respectively. Associations were modestly attenuated after adjusting for social and lifestyle factors. Findings of the benefit of social networks and support to biological aging processes provide evidence of potential physiological underpinnings of social interactions on health outcomes.
Indexed as
AgingAtherosclerosisSocial SupportAgedFemaleHumansMaleMiddle AgedProteomicsRisk Factorsage accelerationatherosclerosis risk in communities studyproteomic aging clocksocial networksocial support
Identifiers
PMID40512629
PMCPMC12936974
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390